Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Successful Haploidentical Hematopoietic Cell Engraftment Using a Non-Myeloablative Preparative Regimen Including Natural Killer (NK) Cells

Sarah Cooley, Purvi Gada, David McKenna, Valarie McCullar, Susan Fautsch, Michael Verneris, Bruce R Blazar, Linda J Burns, Philip B McGlave, MD, Daniel J. Weisdorf, Jeffrey S Miller

Blood (2008) 112 (11): 827.

https://doi.org/10.1182/blood.V112.11.827.827

Published: 2008

Journal Articles

Encouraging Results of Reduced Intensity Conditioning (RIC) Umbilical Cord Blood (UCB) Transplantation for the Treatment of Advanced Lymphoid Malignancies.

Claudio G. Brunstein, MD, Susana Cantero, MD, Qing Cao, MS, Navneet Majhail, MD, Brian McClune, DO, Linda J. Burns, MD, Marcie Tomblyn, MD, Jeffrey S. Miller, MD, Bruce R. Blazar, MD, Philip B. McGlave, MD, Daniel J. Weisdorf, MD, John E. Wagner, MD

Blood (2007) 110 (11): 2028.

https://doi.org/10.1182/blood.V110.11.2028.2028

Published: 2007

Journal Articles

The Predictive Value of the Hematopoietic Cell Transplantation (HCT)-Specific Comorbidity Index (CI) in Recipients of Umbilical Cord Blood (UCB) Transplantation.

Claudio G. Brunstein, MD, PhD, Navneet Majhail, MD, MS, Daniela C. Setubal, MD, Todd E. DeFor, MS, Jeffrey S. Miller, MD, Philip B. McGlave, MD, Bruce R. Blazar, MD, Daniel J. Weisdorf, MD, John E. Wagner, MD

Blood (2007) 110 (11): 5065.

https://doi.org/10.1182/blood.V110.11.5065.5065

Published: 2007

Journal Articles

A Novel Triple Umbilical Cord Blood Transplant (UCBT) Strategy To Promote NK Cell Immunotherapy (Unit 1) with a Fully Ablative Preparative Regimen Followed by a Double UCBT in Patients with Refractory AML.

Jeffrey S. Miller, MD, Claudio G. Brunstein, MD, Sarah Cooley, MD, Michael R. Verneris, MD, Angela Panoskaltsis-Mortari, MD, Linda J. Burns, MD, David McKenna, MD, Kathryn Dusenbery, MD, Cladd Stevens, MD, Pablo Rubensten, MD, Marcie Tomblyn, MD, Mukta Arora, MD, Margaret L. MacMillan, MD, Todd DeFor, PhD, Chap Le, PhD, Philip B. McGlave, MD, Bruce R. Blazar, MD, Daniel J. Weisdorf, MD

Blood (2006) 108 (11): 3111.

https://doi.org/10.1182/blood.V108.11.3111.3111

Published: 2006

Journal Articles

Optimal NK Cell Expansion Depends on Accessory Cells, Synergy between Physiologic Concentrations of IL-2 and IL-15, and Umbilical Cord Blood (UCB) NK Cell Precursors Expand Better Than Adult NK Cells.

Purvi Gada, MBBS, Michelle Gleason, Valarie McCullar, Philip B. McGlave, MD, Jeffrey S. Miller, MD

Blood (2006) 108 (11): 3642.

https://doi.org/10.1182/blood.V108.11.3642.3642

Published: 2006

Journal Articles

Successful Remission of Poor Prognosis AML after Adoptive Transfer and In Vivo Expansion of Human Haploidentical NK Cells.

Jeffrey S. Miller, MD, Yvette Soignier, Angela Panosskaltsis-Mortari, PhD, David McKenna, MD, Chap Le, PhD, Todd E. Defor, PhD, Linda J. Burns, MD, Paul J. Orchard, MD, Bruce R. Blazar, MD, John E. Wagner, MD, Arne Slungaard, MD, Daniel J. Weisdorf, MD, Ian J. Okazaki, MD, Philip B. McGlave, MD

Blood (2004) 104 (11): 260.

https://doi.org/10.1182/blood.V104.11.260.260

Published: 2004

NARROW

Successful Haploidentical Hematopoietic Cell Engraftment Using a Non-Myeloablative Preparative Regimen Including Natural Killer (NK) Cells

Encouraging Results of Reduced Intensity Conditioning (RIC) Umbilical Cord Blood (UCB) Transplantation for the Treatment of Advanced Lymphoid Malignancies.

The Predictive Value of the Hematopoietic Cell Transplantation (HCT)-Specific Comorbidity Index (CI) in Recipients of Umbilical Cord Blood (UCB) Transplantation.

A Novel Triple Umbilical Cord Blood Transplant (UCBT) Strategy To Promote NK Cell Immunotherapy (Unit 1) with a Fully Ablative Preparative Regimen Followed by a Double UCBT in Patients with Refractory AML.

Optimal NK Cell Expansion Depends on Accessory Cells, Synergy between Physiologic Concentrations of IL-2 and IL-15, and Umbilical Cord Blood (UCB) NK Cell Precursors Expand Better Than Adult NK Cells.

Successful Remission of Poor Prognosis AML after Adoptive Transfer and In Vivo Expansion of Human Haploidentical NK Cells.

Email alerts

ASH Publications

American Society of Hematology

Successful Haploidentical Hematopoietic Cell Engraftment Using a Non-Myeloablative Preparative Regimen Including Natural Killer (NK) Cells

Encouraging Results of Reduced Intensity Conditioning (RIC) Umbilical Cord Blood (UCB) Transplantation for the Treatment of Advanced Lymphoid Malignancies.

The Predictive Value of the Hematopoietic Cell Transplantation (HCT)-Specific Comorbidity Index (CI) in Recipients of Umbilical Cord Blood (UCB) Transplantation.

A Novel Triple Umbilical Cord Blood Transplant (UCBT) Strategy To Promote NK Cell Immunotherapy (Unit 1) with a Fully Ablative Preparative Regimen Followed by a Double UCBT in Patients with Refractory AML.

Optimal NK Cell Expansion Depends on Accessory Cells, Synergy between Physiologic Concentrations of IL-2 and IL-15, and Umbilical Cord Blood (UCB) NK Cell Precursors Expand Better Than Adult NK Cells.

Successful Remission of Poor Prognosis AML after Adoptive Transfer and In Vivo Expansion of Human Haploidentical NK Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only